ClinicalTrials.govpublic full text
Phase II Neoadjuvant in Inflammatory Breast Cancer
breast cancer, inflammatory breast cancer, ibc, erbb2 overexpression, lapatinib, paclitaxel, 5-fluorouracil, epirubicin, cyclophosphamide, neoadjuvant chemotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 850764
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.